Skip to main content
. 2019 Mar 29;69(2):343–354. doi: 10.1136/gutjnl-2018-317725

Figure 5.

Figure 5

CR-T3-SEQ13 vaccination could eradicate HBsAg and HBV DNA in hydrodynamic injection-based HBV carrier mice. A total of five doses of CR-T3-SEQ13 were injected at week 0, 2, 3, 4 and 5, respectively. (A) Dynamics of HBsAg level and (B) kinetics of anti-HBs antibody level in HDI-HBV carrier mice (genotype A, n=5). The data represent mean±SEM. HBsAg, hepatitis B virus surface antigen.